Cerebral palsy is a condition or disorder responsible for impairment of movement and coordination in muscles of the body that may lead to permanent loss of movement in the body. It may further impact sensation, swallowing, vision, speaking, and hearing faculties in many cases. Common symptoms of cerebral palsy include continuous drooling, muscle stiffness, weakness, tremors, poor coordination, and neurological complications, such as, intellectual disability, seizures, etc. According to CDC, in the U.S., 1.5 to 4 in every 1000 children are diagnosed with cerebral palsy. The disorder mostly arises due to abnormal development or damage of those parts of the brain which are responsible for controlling movements, posture, and balance. Cerebral palsy, most commonly, appears before birth, nevertheless, its complications may also arise during child birth or soon after birth. Different risks factors involved with this condition include methylmercury exposure during pregnancy, preterm birth, infections during pregnancy — rubella, German measles, toxoplasmosis, and herpes simplex, difficulties in delivery, asphyxia neonatorum, and intracranial hemorrhage.
Rise in incidence of cerebral palsy can be attributed to multiple factors, such as, premature birth or low weight at the time of birth, multiple child births, and incidence of infectious diseases at the time of pregnancy. Further, health conditions of the mother may also lead to cerebral palsy in the child through conditions such as thyroid, seizures, intellectual disability, and so on. Rapid growth of the cerebral palsy treatment market can be attributed to increase in incidence of cerebral palsy, coupled with rise in awareness among parents regarding complications of cerebral palsy and availability of various treatments options in the market. However, side effects associated with the drugs are expected to limit the growth of the cerebral palsy treatment market in the next few years.
The global cerebral palsy treatment market can be segmented based on drug type, type of cerebral palsy, and region. In terms of drug type, the cerebral palsy treatment market can be categorized into anticonvulsants drugs, anticholinergic drugs, antidepressants drugs, anti-inflammatory drugs, and others. Based on type of cerebral palsy, the market can be classified into dyskinetic cerebral palsy, spastic cerebral palsy, hypotonic cerebral palsy, mixed cerebral palsy, and ataxic cerebral palsy.
In terms of geography, the global cerebral palsy treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is likely to account for a major share of the global cerebral palsy treatment market in 2018 due to increase in investment in R&D, rise in awareness among people regarding mental health, favorable regulations and reimbursement policies implemented by governmental bodies, and growing health care expenditure in the region. Europe, followed by Asia Pacific, is projected to be highly lucrative markets for cerebral palsy treatment in the near future. The cerebral palsy treatment market in Asia Pacific is expected to grow rapidly during the forecast period. Increasing population and growing support in terms of investment from both public and private sectors are expected to drive the market in the region in the near future. Furthermore, increasing awareness among people regarding complications and treatment of cerebral palsy, coupled with rising technological penetration, is anticipated to further support the growth of the cerebral palsy treatment market. The cerebral palsy treatment market in Middle East & Africa and Latin America is likely to grow substantially during the forecast period due to introduction of favorable governmental norms and increase in expenditure on health care by both public and private bodies.
Key players operating in the cerebral palsy treatment market include Allergen Plc., Cellular Biomedicine Group, Merck & Co., Inc., Pfizer Inc., GlaxoSmithKline plc, Abbott, Acorda Therapeutics, Inc., Medtronic, Meridigen Biotechnology, and GW Pharmaceuticals Plc.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.
TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.
Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:
Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.
Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.
Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.